Real-World test of aortic Stent-Graft aims to confirm safety and training
NCT ID NCT06578741
First seen Feb 19, 2026 · Last updated Jun 23, 2026 · Updated 21 times
Summary
This study follows 300 people who receive the GORE TAMBE device, a stent-graft for complex aneurysms in the abdomen and chest. Researchers want to see if the device works well in real-world settings and if the training program for doctors is adequate. Participants are tracked for 12 months to check for complications like leaks, blockages, or need for further surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL AORTIC ANEURYSM are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Stanford Hospital
Stanford, California, 94305, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) – a stent-graft device placed inside the aorta to repair aneurysms
What this could lead to
If successful, this study will confirm that the TAMBE device is a safe and effective option for treating complex aortic aneurysms in everyday medical practice.
What could go wrong
This is a post-approval study, not a new treatment test. It mainly monitors real-world outcomes, so no major breakthrough is expected. Risks include device complications like leaks, blockages, or need for additional procedures.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.